In my role as a hospital manager I am still challenged to reach this goal everyday. Many years of experience in a leadership position do not guarantee the mastering of a perfect management style. One of the reasons for this is the need for continuous change. You have to adapt your leadership style and position as the values of staff members change constantly. Recent considerations have shown that achieveme

Association News

President of EAHM, Mr. Heinz Kölking welcomed members to the General Assembly and started by saying a few words about our dear colleague and long-standing EAHM member Asger Hansen who passed away in 2011. After a moment of silence the General Assembly got underway. Zurich 2010.This year’s agenda and the minutes from the 40th Ordinary General Assembly were unanimously approved. After this it was tim

Conference News

The morning section focused on current European health policy with a keynote presentation by Mars Di Bartolomeo, Minister of Health and Social Affairs, Luxembourg.The afternoon was devoted to the EU Directiveon Patients’ Rights and its impacton hospitals. The key presentation was given by Annika Nowak, European Commission and was followed by comments from various European countries (UK, Hungary, France,

National News

From the 19th to the 25th of September2011, the Belgian Association of Hospital Managers organised a study trip to Boston, the capital of New England. Around 40 hospital manager stook this great opportunity to visit arange of interesting hospitals. On the programme: Tufts Medical Centre, a world-class academic centre. This medical centre is the principal teaching hospital for Tufts University School o

Cover Story

Definition Ethical Governance refers to values and ethical behaviours, processes, procedures, culture, ways of doing and being that ensure high standards of performance, economy, effectiveness, efficiency, quality, satisfaction. Governance is the set of processes and abilities needed to achieve the objectives and fullfil the responsabilities of whatever business ororganisation, whether public, for p

1. Leadership, Behaviour and Management Style Presence of a charismatic leadership, highly competent, able to suggest and share the vision of the organisation which means having the ability to answer or knowledge to answer the question: “for whom and for what do we exist”. Able to create a culture of excellence and honesty. Able to promote and encourage high ethical standards. 2. Communication

As part of the communications strategy the need for succinct information on clinical governance was identified. This article provides an overview of the clinical governance development material prepared for this purpose. The objective was to inform the wider health community of the vision, benefits and guiding principles for clinical governance along with gaining momentum and support for implementation of


Last October in Venice, Italy, 16 European professional and scientific societies from 14 countries involved ininfection prevention and control formed EUNETIPS- a European network to promote infection prevention forpatient safety. The goal of EUNETIPS to promote better cooperation among nations, to share experiences,to promote and support initiatives in infection prevention for patient safety particularly a


2011 Saw the Start of Your Mandate of President of EAHM. How was Your First Year in Charge and What did You Accomplish? As I have been active member of the association (Board and Executive Committee) for a long time now there is a certain continuity within the Presidency. The main activities of my Presidency focus on the implementation of the results of our reflection process; this is a perquisite for t

Pharma Special

The rapid growth of pharmaceutical expenditure driven by changing demographics, strict clinical targets, rising patient expectations and the continued launch of new expensive drugs has become a contentious issue in the healthcare sector. New expensive drugs include new biological drugs marketed at considerably higher costs than previous standards, which now account for over 50% of in-patient drug costs amo

To acheive marketing approval, a molecule  undergoes different development  phases and a variety of studies need to  be carried out. A new molecule typically  involves preclinical testing in animals followed  by clinical trials in humans, after  which the application is submitted to regulatory  agencies for review. In case of new  delivery system, since drug molecule

Author  Jill Davis,  Interview by Lee Campbell   Firstly What are Cytotoxic Drugs and What  do We Use Them For?   Cytotoxic drugs are drugs that kill cells. They  are mainly used to treat cancer but can be  used for other therapeutic indications e.g.  rheumatoid arthritis, multiple sclerosis. Cytotoxic  drugs mainly kill cells through their

Small institutions should eliminate the risk by outsourcing the preparation of cytotoxic drugs.  Otherwise, centralise the preparation of cytotoxic drugs under the control of the pharmacy department. Involve the appropriate people within the pharmacy department in all aspects of planning and  design and operation of cancer chemotherapy services. Ensure risk is minimised by i) separating


IT @ Networking Awards 2012 - 2nd PlaceIntroducing Innovation in  Healthcare   These advances in genomic medicine are  only possible due to the equal progress  in the information technology sector. The  diagnostic opportunities also bring new  challenges to medical centres regarding  privacy in general and the necessary ICT  infrastructure to secure this priva

It is globally recognised that the only way to effectively support continuity of care is to implement an electronic  health record (EHR) system on a large scale. The implementation of a national EHR is a high priority in  the e-health strategies of most countries, regardless of whether they are first world or low- and middle-income  countries. In South Africa, this has been successfully achi

IT @ Networking Awards 2012 - 3rd Place   The LV Prasad Eye Institute (LVPEI) was established  in 1986-87 at Hyderabad as a not-for-profit, nongovernment,  public-spirited, comprehensive eye  care institution. From its very beginning, it set forth  as its core values the “Three E’s”: Equity, Efficiency  and Excellence. Equity translates as treating all patients  

All licensed drugs have trial evidence that  they work within their licensed indications,  otherwise they would not have been  granted a marketing authorisation by bodies  such as the European Medicines  Agency. Nevertheless they do not necessarily  have to work particularly well or sufficiently  well to justify their cost compared  with other available treatments. &


Challenges, Plans and Solutions   Norway faces the same dilemma of many western  European countries, as the standard of living  improves and people’s life expectancy increases,  there are new challenges with an ageing  population and a growing number of people  with chronic diseases. An ageing society will be  a challenge for the Norwegian healthcare system.  To

No comment

Please login to leave a comment...